Article Figures & Data
Tables
No. of stents deployed 0 6 1 136 2 10 Stent modalities Balloon-mounted, bare metal 78 Balloon-mounted, drug-eluting 21 Self-expanding 47 Total 146 Anesthesia technique MAC 36 GETA 106 Stent types AVE Series 53 Bx Velocity 11 Driver 15 Palmaz 2 Wingspan 37 Othera 28 Total 146 Stent-designed indications Coronary 95 Neuro 40 Peripheral 11 Total 146 Angiographic results Mori Pretreatment stenosis Posttreatment stenosis Success A (n = 19) 80.8% 3.9% 84.2% B (n = 73) 80.2% 7.8% 89.0% C (n = 50) 86.0% 13.8% 86.0% Note:—MAC indicates monitors anesthesia care; GETA, general endotracheal anesthesia.
↵a Cypher, Enterprise, Herculink, Multi-Link, Neuroform, NIR Primo, Precise, Sprint, Taxus.
OR 95% CI P Value mRS >2 at last contact Tandem 0.319 0.143–0.713 .005 Hyperlipidemia 3.158 1.220–8.173 .018 Antiplatelet 3.907 1.107–13.792 .034 Tobacco 0.437 0.197–0.968 .041 Death at last contact Tandem 0.297 0.111–0.799 .016 Antiplatelet 4.504 1.017–19.949 .047 Diabetes 0.432 0.175–1.065 .068 PTA SES 4.028 0.875–18.532 .074 Tobacco 0.451 0.185–1.099 .080 Sex 2.285 0.649–8.042 .198 Neuro stent 1.725 0.393–7.565 .470
In this issue
Symptom Differences and Pretreatment Asymptomatic Interval Affect Outcomes of Stenting for Intracranial Atherosclerotic Disease
Jump to section
Related Articles
Cited By...
- Factors associated with perforator stroke after selective basilar artery angioplasty or stenting
- Vessel wall imaging for intracranial vascular disease evaluation
- Lesion location, stability, and pretreatment management: factors affecting outcomes of endovascular treatment for vertebrobasilar atherosclerosis
- Lesion stability characteristics outperform degree of stenosis in predicting outcomes following stenting for symptomatic intracranial atherosclerosis